Minghui Pharmaceutical Announces FDA clearance of IND to Initiate Global Phase Ⅲ Trials of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Thyroid Eye Disease
SHANGHAI and HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced the U.S. Food and Drug...
What Holds the Internet Together and Why It's Now at Risk
A new report from ICANN and the Internet Society details how the Internet Governance Forum has supported a stable and secure Internet—and why that model is now under strain. PRAGUE, June 10, 2025 /PRNewswire/ -- As global discussions intensify...
IGF Continues to Enrich the Global Digital Dialogue
Forum serves as a global innovation and digital transformation platform RIYADH, Saudi Arabia, Dec. 19, 2024 /PRNewswire/ -- The 19th edition of the United Nations Internet Governance Forum (IGF) continues to unfold at the King Abdulaziz...
